Portfolio Tracker
Dein Depot in Echtzeit – Kurse, Renditeanalyse und Dividendenplaner an einem Ort.
Anzeige
EQS-News

Indian Prime Minister Mr. Narendra Modi launches IIT Madras mission to create 3D atlases of 100+ Human Brains 18.11.2026, 10:35 Uhr von EQS News Jetzt kommentieren: 0

EQS-News: IIT Madras / Key word(s): Product Launch
Indian Prime Minister Mr. Narendra Modi launches IIT Madras mission to create 3D atlases of 100+ Human Brains

18.11.2026 / 10:35 CET/CEST
The issuer is solely responsible for the content of this announcement.


Sudha Gopalakrishnan Brain Centre at IIT Madras, India's No. 1-ranked engineering institute, aims to create the world's largest set of whole-human-brain 3D maps at cellular resolution, advancing research into brain structure, development and disease

CHENNAI, India, Nov. 18, 2026 /PRNewswire/ -- Hon'ble Indian Prime Minister Mr. Narendra Modi launched a path breaking brain research at India's No. 1-ranked engineering institute, the Indian Institute of Technology Madras (IIT Madras).

Hon'ble PM Mr. Narendra Modi with Prof Mohanasankar Sivaprakasam, Head, Sudha Gopalakrishnan Brain Centre IITM on 11 Oct 2026

Mr. Narendra Modi on 11th October 2026 launched IIT Madras Sudha Gopalakrishnan Brain Centre's (SGBC) scientific mission to create 3D atlases of 100+ human brains at cellular resolution, spanning the human lifespan from foetal stage to old age, and including brain-related diseases.

The mission aims to create the world's largest collection of whole-human-brain 3D maps at cellular resolution, advancing research into brain structure, development, and disease.

The mission uses SGBC's advanced imaging, computing and data visualisation technologies to transform whole post-mortem human brains into detailed digital maps. These resources will be publicly accessible, enabling researchers and medical professionals worldwide to explore human brain structure in unprecedented detail.

Mr. Kris Gopalakrishnan, IIT Madras Distinguished Alumnus, Infosys Co-founder and a major donor, said, "The Prime Minister's visit would inspire scientists and encourage philanthropists to support and scale up world-class research in India."

Prof. Mohanasankar Sivaprakasam, Head of SGBC, IIT Madras, said, "The initiative brings together brain science, engineering, medicine and technology, with the potential to shape neuroscience and neuromedicine for decades."

At the launch, the Hon'ble Prime Minister also released C-STROKE, the world's first 3D atlas of an ischemic stroke-affected human brain. Supported by IIT Madras Distinguished Alumnus Mr. Prem Watsa, Chairman of Fairfax Financial, the atlas connects clinical Magnetic Resonance Imaging (MRI) scans with microscopic examination of brain tissue.

Featuring over 1000 annotated brain sections, C-STROKE maps cellular indicators of neuronal health, neuroinflammation, blood-brain barrier disruption, oxygen deprivation and axonal injury. Its open-access visualisation and analytical tools will help researchers investigate stroke pathology and identify potential therapeutic targets.

The Centre has already released atlases of second trimester fetal brain development 'DHARANI' (2025), and brain stem of fetus, child, adult 'ANCHOR' (2026).

The broader mission brings together more than 200 researchers, engineers and technicians at SGBC, over 10 Indian medical institutions, and over 30 leading researchers from over 10 countries. The Centre is currently supported by over 20 industries and philanthropies.

 

Hon’ble PM Mr. Narendra Modi at Sudha Gopalakrishnan Brain Centre in IIT Madras on 11 Oct 2026

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/indian-prime-minister-mr-narendra-modi-launches-iit-madras-mission-to-create-3d-atlases-of-100-human-brains-302943599.html

rt.gif?NewsItemId=EN01087&Transmission_Id=202611180430PR_NEWS_EURO_ND__EN01087&DateId=20261118


18.11.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2437582  18.11.2026 CET/CEST

Kommentare (0) ... diskutiere mit.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer